Evidence map›Paper›PMID 29419426›Full record

ArticleHaematologica2018

Heterozygous carriers of germline c.657_661del5 founder mutation in

Bartłomiej Tomasik, Agata Pastorczak, Wojciech Fendler, Marcin Bartłomiejczyk, Marcin Braun, Marcin Mycko, Joanna Madzio, Ewa Polakowska, Edyta Ulińska, Michał Matysiak and 10 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Bartłomiej TomasikDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Agata PastorczakDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Wojciech FendlerDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Marcin BartłomiejczykDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Marcin BraunDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Marcin MyckoDepartment of Neurology, Medical University of Lodz, Poland.
Joanna MadzioDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Ewa PolakowskaDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.
Edyta UlińskaDepartment of Pediatric Hematology and Oncology, Medical University of Warsaw, Poland.
Michał MatysiakDepartment of Pediatric Hematology and Oncology, Medical University of Warsaw, Poland.
Katarzyna DerwichDepartment of Pediatric Oncology, Hematology and Transplantology, Medical University of Poznan, Poland.
Monika LejmanDepartment of Pediatric Oncology and Hematology, Medical University of Lublin, Poland.
Jerzy KowalczykDepartment of Pediatric Oncology and Hematology, Medical University of Lublin, Poland.
Wanda BadowskaDivision of Pediatric Hematology and Oncology, Children Hospital, Olsztyn, Poland.
Bernarda KazanowskaDepartment and Clinic of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Poland.
Tomasz SzczepańskiDepartment of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
Jan StyczyńskiDepartment of Pediatrics, Hematology and Oncology, Nicolaus Copernicus University, Bydgoszcz, Poland.
Nina Irga-JaworskaDepartment of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Poland.
Wojciech MłynarskiDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland wojciech.mlynarski@umed.lodz.pl.
Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)
Medical University of Lodz · PLMedical University of Warsaw · PLMedical University of Lublin · PLGdańsk Medical University · PLMedical University of Silesia · PLNicolaus Copernicus University · PLPoznan University of Medical Sciences · PLUniversity of Computer Sciences and Economics in Olsztyn · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Germ-Line MutationHeterozygoteAdolescentCell Cycle ProteinsCentral Nervous System NeoplasmsChildChild, PreschoolFemaleFollow-Up StudiesFounder EffectHumansInfantMaleNeoplasm Recurrence, LocalNuclear ProteinsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaCell Cycle ProteinsNBN protein, humanNuclear Proteins

Identifiers

PMID29419426
PMCPMC5927986
OpenAlexW2792132767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.